Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

Patent 11767320 was granted and assigned to Incyte on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Wenqing Yao

Taisheng Huang

Xiaozhao Wang

Date of Patent

September 26, 2023

Patent Application Number

17449696

Date Filed

October 1, 2021

Patent Citations

US Patent 7973163 Fused quinoline derivative and use thereof

US Patent 7592453 Fused quinoline derivative and use thereof

US Patent 7897609 Aryl substituted imidazonaphthyridines

US Patent 7943770 Fused quinoline derivative and use thereof

US Patent 9550776 Pyridinylpyrazoloquinoline compounds

US Patent 9573947 Salt of pyrazoloquinoline derivative, and crystal thereof

US Patent 9694006 Use of pyrroloquinoline compounds to kill clinically latent microorganisms

US Patent 9771327 Compounds and methods for the treatment of cystic fibrosis

...

Patent Primary Examiner

CPC Code

Patent abstract

Disclosed are compounds of Formula I, methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with KRAS activity such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool